Other Health Care Provider

Preventing Asthma Attacks among Native American Children

Home Is Where the Triggers Are: Increasing Asthma Control by Improving the Home Environment
PEDIATRIC ALLERGY, IMMUNOLOGY, AND PULMONOLOGY Volume 23, Number 2: 139-45, 2010

This card is meant to help the patients prepare for their visit with their provider

This tool lists controller and quick relief medications, their class, age recommendation, doses/strengths, and priming protocols.

This is a concise reference in an easy-to-use format based on the NHLBI Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, 2007.

Interactive Asthma Action Plan (iAAP)
The Minnesota Department of Health's Asthma Program recently launched a new, interactive Asthma Action Plan (iAAP), a computerized clinical decision support tool for licensed health care providers who treat patients with asthma. The iAAP assists asthma providers/prescribers in determining the appropriate severity and asthma control, using the EPR-3 Guidelin

Podcast en español sobre la importancia de mantener el aire libre de alérgenos al interior de los hogares

James Sublett, MD, a board-certified allergist and indoor air specialist from Louisville, Kentucky, and a member of the Board of Regents Executive Committee for the American College of Allergy, Asthma & Immunology talks with AANMA about ways to reduce allergens and irritants at home.

AANMA¿s Indoor AIRepair at Home, School and Play (HSP) kit is one of our most recognizable educational materials for patient education. The kit helps children with asthma, their parents, relatives, school administrators, and other community members recognize the correlation between good indoor air quality and improved asthma symptoms. English and Spanish version are compiled in a electronic versi

Numerous studies that observe patient technique for using inhaled medications consistently have shown low levels of proficiency with the best rates up to just 55% among children. Without proper inhalation technique, optimal medication delivery to the lungs cannot be achieved. This paper examines the need, recommendations and health care provider reimbursement process for assessing the inhalation t